How to buy Masimo Corporation stock (MASI)

Masimo Corporation is a medical devices business based in the US. Masimo Corporation shares (MASI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $169.52 – a decrease of 3.76% over the previous week. Masimo Corporation employs 3,800 staff and has a trailing 12-month revenue of around $2 billion.

Our top picks for where to buy Masimo Corporation stock

Buy Masimo Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Masimo Corporation stock price (NASDAQ: MASI)

Use our graph to track the performance of MASI stocks over time.

Masimo Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$169.52
52-week range	$101.61 - $180.97
50-day moving average more info button	$158.15
200-day moving average more info button	$133.67
Wall St. target price	$172.77
PE ratio more info button	117.6759
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.45

Is it a good time to buy Masimo Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Masimo Corporation price performance over time

Historical closes compared with the close of $169.52 from 2024-12-20

1 week (2024-12-13)	-3.76%
1 month (2024-11-22)	-1.99%
3 months (2024-09-20)	39.61%
6 months (2024-06-21)	29.24%

1 year (2023-12-22)	43.62%
2 years (2022-12-22)	13.19%
3 years (2021-12-22)	289.89
5 years (2019-12-20)	6.90%

Is Masimo Corporation stock undervalued or overvalued?

Valuing Masimo Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Masimo Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Masimo Corporation's P/E ratio

Masimo Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 118x. In other words, Masimo Corporation shares trade at around 118x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Masimo Corporation's PEG ratio

Masimo Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.7295. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Masimo Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Masimo Corporation's EBITDA

Masimo Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $199 million.

The EBITDA is a measure of a Masimo Corporation's overall financial performance and is widely used to measure a its profitability.

Masimo Corporation financials

Revenue TTM	$2 billion
Operating margin TTM	5.97%
Gross profit TTM	$1.1 billion
Return on assets TTM	2.66%
Return on equity TTM	5.74%
Profit margin	3.85%
Book value	$27.33
Market Capitalization more info button	$9.1 billion

TTM: trailing 12 months

Masimo Corporation share dividends

We're not expecting Masimo Corporation to pay a dividend over the next 12 months.

Masimo Corporation share price volatility

Over the last 12 months, Masimo Corporation's shares have ranged in value from as little as $101.61 up to $180.97. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Masimo Corporation's is 0.973. This would suggest that Masimo Corporation's shares are less volatile than average (for this exchange).

Masimo Corporation overview

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth. com, amazon. com, and shopify. com.

Frequently asked questions

What percentage of Masimo Corporation is owned by insiders or institutions?
Currently 8.185% of Masimo Corporation shares are held by insiders and 94.989% by institutions. How many people work for Masimo Corporation?
Latest data suggests 3,800 work at Masimo Corporation. When does the fiscal year end for Masimo Corporation?
Masimo Corporation's fiscal year ends in December. Where is Masimo Corporation based?
Masimo Corporation's address is: 52 Discovery, Irvine, CA, United States, 92618 What is Masimo Corporation's ISIN number?
Masimo Corporation's international securities identification number is: US5747951003 What is Masimo Corporation's CUSIP number?
Masimo Corporation's Committee on Uniform Securities Identification Procedures number is: 574795100